Association between different anticholinergic drugs and subsequent dementia risk in patients with diabetes mellitus
Sign Up to like & getrecommendations! Published in 2017 at "PLoS ONE"
DOI: 10.1371/journal.pone.0175335
Abstract: Background The effects of oxybutynin, solifenacin and tolterodine on dementia risk in patients with diabetes mellitus (DM) remain unknown. We investigated the effects of oxybutynin, solifenacin and tolterodine on dementia risk in patients with DM.… read more here.
Keywords: dementia risk; tolterodine; oxybutynin solifenacin; dementia ... See more keywords